Advances in Alzheimer's Disease

Sponsored by CME Outfitters, LLC.

Supported by an educational grant from Lilly.

Release date: November 27, 2013

Valid through: November 27, 2014

Target Audience:

Physicians, pharmacists, and other health care professionals who manage patients with Alzheimer's disease.

Program Overview:

The National Institutes of Health (NIH) recently funded an exhaustive review by the Agency for Healthcare Research and Quality (AHRQ), performed through its Evidence-Based Practice Centers. This review highlights the presence of critical gaps in current knowledge about Alzheimer's disease (AD) and the progression of cognitive impairment. In addition to recommending continued research into the science of AD, the review emphasized the need for education to the clinicians who treat individuals with dementia to translate the latest research and emerging therapies into meaningful, clinical approaches. The recently published fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) has modified and enhanced the way clinicians will describe dementia and emphasizes the need for earlier assessment of neurocognitive disorders.

This neuroscienceCME Snackā„¢ explores the current and emerging science in the management of individuals with AD and challenges clinicians to keep up-to-date on differential diagnosis (e.g., MCI and AD) and offer the best, evidence-based care for their patients with AD.

Credit Types

1.0 AMA PRA Category 1™ Credit Hour

1.0 Nursing Contact Hours